Skip to main content
Birkhäuser

Valproate

  • Book
  • © 1999

Overview

Part of the book series: Milestones in Drug Therapy (MDT)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (11 chapters)

  1. The discovery of valproate

  2. The pharmacology of valproate

  3. Clinical use of valproate

Keywords

About this book

Since the fortuitous discovery of its anticonvulsant activIty in 1962, valproate has established itself worldwide as a major antiepileptic drug against several types of epileptic seizures. Clinical experience with valpro­ ate has continued to grow in recent years, including use of valproate for diseases other than epilepsy, for example in bipolar disorders and migraine. In this volume on valproate emphasis is placed on the scientific back­ ground leading to the discovery of val pro ate, its subsequent pharmacologi­ cal and toxicological characterization, and its clinical development into one of the most widely and successfully used anti epileptic drugs, a real mile­ stone in drug therapy. The current state of knowledge of valproate will be reviewed by experts in the field, including new hypotheses about its mecha­ nisms of action, its metabolism into pharmacologically active metabolites, its unique distribution characteristics, its unwanted hepatotoxic and terato­ genic adverse effects and its various clinical uses. Furthermore, the wide variety of available pharmaceutical formulations of valproate, including novel controlled-release formulations, will be outlined. The monograph is aimed at a broad readership, particularly neurologists, psychiatrists and basic scientists working in the field of epilepsy research. Because the monograph also deals with structure-activity relationships of valproate as well as of its metabolites and analogs, the book should also serve for rese­ archers working in medicinal chemistry, particularly in the pharmaceutical industry.

Editors and Affiliations

  • Department of Pharmacology, Toxicology, and Pharmacy, School of Veterinary Medicine, Hannover, Germany

    Wolfgang Löscher

Bibliographic Information

  • Book Title: Valproate

  • Editors: Wolfgang Löscher

  • Series Title: Milestones in Drug Therapy

  • DOI: https://doi.org/10.1007/978-3-0348-8759-5

  • Publisher: Birkhäuser Basel

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Basel AG 1999

  • Hardcover ISBN: 978-3-7643-5836-5Published: 01 July 1999

  • Softcover ISBN: 978-3-0348-9761-7Published: 13 October 2012

  • eBook ISBN: 978-3-0348-8759-5Published: 06 December 2012

  • Series ISSN: 2296-6056

  • Series E-ISSN: 2296-6064

  • Edition Number: 1

  • Number of Pages: XV, 286

  • Topics: Pharmacology/Toxicology, Neurology, Medicinal Chemistry

Publish with us